Cytological Diagnosis of Pleural Effusions Based on the International System for Reporting Serous Fluid Cytopathology and Its Histopathological Correlation
DOI:
https://doi.org/10.21276/apalm.3554Keywords:
Serous effusion cytology, Pleural effusion, Cytopathology, Non-Diagnostic, Negative for Malignancy, Atypia of Undetermined Significance, Suspicious for Malignancy, MalignancyAbstract
Background: This study classifies pleural fluid cytology using the International System for Reporting Serous Fluid Cytopathology (TIS, 2021) and evaluates the Risk of Malignancy (ROM) through histopathological correlation. Conducted over two years at a tertiary care hospital, it aims to assess the diagnostic and prognostic value of TIS in managing serous effusions.
Materials and Methods: Pleural fluid samples were categorized using the International System for Reporting Serous Fluid Cytopathology, and histopathological slides were reviewed to assess the ROM. Statistical analysis was performed using descriptive statistics, and diagnostic parameters including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy were calculated to evaluate the effectiveness of the TIS classification in predicting malignancy.
Results: Among 260 cases, 4 (1.53%) were Non-Diagnostic (ND), 214 (82.31%) Negative for Malignancy (NFM), 9 (3.46%) Atypia of Undetermined Significance (AUS), 9 (3.46%) Suspicious for Malignancy (SFM), and 24 (9.23%) Malignancy (MAL). ROM was 33.33% in ND, 19.86% in NFM, 50% in AUS, 66.67% in SFM, and 50% in MAL. Sensitivity, specificity, and diagnostic accuracy varied across categories.
Conclusion: TIS is a reliable system for reporting pleural effusions. ROM is highest in the AUS, SFM, and MAL categories. Consistency in diagnostic criteria and further refinement in ND and NFM categories are necessary for improved clinical outcomes.
References
1. Davidson B. Molecular testing on serous effusions. Diagn Cytopathol. 2021 May;49(5):640-6.
2. Yu GH, Glaser LJ, Gustafson KS. Role of ancillary techniques in fluid cytology. Acta Cytol. 2020 Jan 7;64(1-2):52-62.
3. Ebata T, Okuma Y, Nakahara Y, Yomota M, Takagi Y, Hosomi Y, et al. Retrospective analysis of unknown primary cancers with malignant pleural effusion at initial diagnosis. Thorac Cancer. 2016 Jan;7(1):39-43.
4. Zamboni MM, da Silva CT, Baretta R, Cunha ET, Cardoso GP. Important prognostic factors for survival in patients with malignant pleural effusion. BMC Pulm Med. 2015 Dec;15:1-7.
5. Ali SZ, Cibas ES. The Bethesda system for reporting thyroid cytopathology. New York: Springer; 2010 Feb 6.
6. Pinto D, Chandra A, Crothers BA, Kurtycz DF, Schmitt F. The international system for reporting serous fluid cytopathology—diagnostic categories and clinical management. J Am Soc Cytopathol. 2020 Nov 1;9(6):469-77.
7. Crothers BA, Chandra A. Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology meeting part 1: towards an international system for reporting serous fluid cytopathology. J Am Soc Cytopathol. 2019 Nov 1;8(6):362-8.
8. Wojcik EM, Kurtycz DF, Rosenthal DL, editors. The Paris system for reporting urinary cytology. New York: Springer; 2022 Jan 1.
9. Faquin WC, Rossi ED, Baloch Z, Barkan GA, Foschini MP, Kurtycz DF, et al., editors. The Milan system for reporting salivary gland cytopathology. Berlin: Springer International Publishing; 2018 Jan 31.
10. Pergaris A, Stefanou D, Keramari P, Sousouris S, Kavantzas N, Gogas H, et al. Application of the International System for Reporting Serous Fluid Cytopathology with cytohistological correlation and risk of malignancy assessment. Diagnostics (Basel). 2021 Nov 28;11(12):2223.
11. Xu Y, Hu AY, Wang SM, Wang Q, Pan YC, Zhang SH. A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology. Diagn Cytopathol. 2021 Sep;49(9):997-1007.
12. Lobo C, Costa J, Petronilho S, Monteiro P, Leça L, Schmitt F. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: experience of an oncological center. Diagn Cytopathol. 2021 May;49(5):596-605.
13. Kundu R, Srinivasan R, Dey P, Gupta N, Gupta P, Rohilla M, et al. Application of Indian academy of cytologists guidelines for reporting serous effusions: an institutional experience. J Cytol. 2021 Jan 1;38(1):1-7.
14. Farahani SJ, Baloch Z. Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature. Diagn Cytopathol. 2019 Nov;47(11):1145-59.
15. Zhu YL, Ren WH, Wang Q, Jin HZ, Guo YY, Lin DM. A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center. Diagn Pathol. 2022 Jul 2;17(1):56.
16. Gonzalez M, Jhala N. Accuracy rate and risk of malignancy of liver cytology. J Am Soc Cytopathol. 2023 Sep 1;12(5):S52.
17. Jha S, Sethy M, Adhya AK. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy. Diagn Cytopathol. 2021 Oct;49(10):1089-98.
18. Valerio E, Nunes W, Cardoso J, Santos A, Bovolim G, Domingos T, et al. A 2-year retrospective study on pleural effusions: a cancer centre experience. Cytopathology. 2019 Nov;30(6):607-13.
19. Yang H, Zhu J, Wang P. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: a retrospective study. Medicine (Baltimore). 2023 Oct 27;102(43):e35707.
20. Sun T, Wang M, Wang H. Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: experience in a community hospital setting and comparison with other studies. Cancer Cytopathol. 2022 Dec;130(12):964-73.
21. Goel S, Yeshvanth SK, Asnani R, Joshi D. Accuracy of bronchial cytological diagnosis in lung lesions in comparison with histopathology. J Cytol. 2022 Oct 1;39(4):163-8.
22. Rodriguez EF, Jones R, Gabrielson M, Santos D, Pastorello RG, Maleki Z. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on reporting pericardial effusion cytology. Acta Cytol. 2020 Sep 2;64(5):477-85.
23. Rossi ED, Bizzarro T, Schmitt F, Longatto-Filho A. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience. Cancer Cytopathol. 2015 Apr;123(4):258-66.
24. Shidham VB. Diagnostic pitfalls in effusion fluid cytology. Cytojournal. 2021;18.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mayur Sayaniya, Hetal Joshi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
